GPC5 and neoplasm: To ascertain the impact of variants on the tumor-suppressive functions of GPC5, to assess the variant’s impact by transfecting LUAD A549 cell lines with vectors expressing GPC5 wild-type (WT) or the c.776C>T mutant (MUT).